EUVIMEDEUVIMED entdecken
Open Access

Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/Vasculitis

Dorey A Glenn iD, Ashley W Carver iD, Margaret E Helmuth, Abigail R Smith iD, Richard A Lafayette iD, Prasanth Ravipati, Andrea L Oliverio iD, Dana V Rizk, Jan Novak iD, Francesca Lugani, Sharon M Bartosh iD, Krzysztof Mucha iD und 16 weitere

Clinical Journal of the American Society of Nephrology · 2025-07 · 20 (7) · 978-992

DOI: 10.2215/cjn.0000000707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 10.04.2025. Verfasst von Dorey A Glenn und 27 weiteren Autor:innen. Beteiligte Einrichtung: University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Defining risk of kidney function loss in IgA nephropathy and IgA vasculitis with nephritis is important for patient counseling and risk-based enrollment of clinical trials. Proteinuria trajectory over 2 years can uniquely identify patients at risk of loss of kidney function or kidney failure. Children and adults with the highest levels of proteinuria had a higher risk of progressive kidney disease compared with those with intermediate levels.

Background

Identifying patients with IgA nephropathy at risk of disease progression is critical for clinical decision making, risk-based patient counseling, and optimal enrollment of clinical trials.

Methods

Patients with IgA nephropathy and IgA vasculitis with nephritis were enrolled in the Cure Glomerulonephropathy Network, a multicenter observational cohort study. Children and adults were analyzed separately in four cohorts: ( 1 ) full, ( 2 ) incident, ( 3 ) prevalent, and ( 4 ) histology. Groups were defined using latent class trajectory modeling using proteinuria measurements over 2 years. Linear mixed models were used to calculate predicted eGFR slope. In adults, Cox proportional hazard models were used to model time to kidney failure or 40% eGFR decline as a function of the proteinuria trajectory group.

Results

Of 919 patients with IgA nephropathy/IgA vasculitis with nephritis enrolled into the Cure Glomerulonephropathy Network, 368 adults and 234 children were included in the analysis. In the full adult cohort, group 1 had the lowest levels of proteinuria (interquartile range [IQR], 0.1–0.4 g/g), while groups 2 and 3 had intermediate and higher levels of proteinuria (IQR, 0.5–1.5 and IQR, 1.8–4.1 g/g), respectively. The average predicted time to eGFR 90, 16, and 8 years and >90, 67, and 11 years for proteinuria trajectory groups 1, 2, and 3 in the full adult and pediatric cohorts, respectively. In adults, adjusting for age, eGFR at enrollment, immunosuppression exposure, and hypertension, group 3 membership was associated with 3.13 (95% confidence interval [CI], 1.84 to 5.33), 1.98 (95% CI, 0.97 to 4.06), and 3.36 (95% CI, 1.59 to 7.13) times higher hazard of progressing to a composite outcome compared with group 2 membership in the full, prevalent, and histology cohorts, respectively, but not associated with progression in the incident cohort.

Conclusions

Proteinuria trajectory is a major predictor of disease progression in patients with IgA nephropathy.

Schlagwörter

Stichwörter der Autor:innen

CKDHenoch-Schonlein purpura (IgA vasculitis)IgA nephropathyclinical epidemiologyglomerular diseasepediatric nephrologypediatrics

Autor:innen und Institutionen

  • University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • University of Michigan, Ann Arbor, Michigan.
  • Northwestern University, Chicago, Illinois.
  • Stanford University Medical Center, Stanford, California.
  • University of Nebraska Medical Center, Omaha, Nebraska.
  • University of Alabama at Birmingham, Birmingham, Alabama.

ORCID-Profile: Dorey A Glenn, Ashley W Carver, Abigail R Smith, Richard A Lafayette, Andrea L Oliverio, Jan Novak, Sharon M Bartosh, Krzysztof Mucha, Krzysztof Kiryluk, Cynthia C Nast, Jean Hou, Laura E Biederman, Nidia Messias, Heather N Reich, Pietro A Canetta, Patrick H Nachman, Carla Nester, Raed Bou-Matar, Myda Khalid

Förderung

  • NIDDK NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Nephcure Foundation

Zitieren

APA

Glenn, D. A., Carver, A. W., Helmuth, M. E., Smith, A. R., Lafayette, R. A., Ravipati, P., Oliverio, A. L., Rizk, D. V., Novak, J., Lugani, F., Bartosh, S. M., Mucha, K., Kiryluk, K., Saha, M. K., Nast, C. C., Hou, J., Biederman, L. E., Messias, N., Rosenberg, A. Z., …, & CureGN IgA Working Group (2025). Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/Vasculitis. Clinical Journal of the American Society of Nephrology, 20(7), 978-992. https://doi.org/10.2215/cjn.0000000707

Vancouver

Glenn DA, Carver AW, Helmuth ME, Smith AR, Lafayette RA, Ravipati P, et al. Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/Vasculitis. Clinical Journal of the American Society of Nephrology. 2025;20(7):978-992. doi:10.2215/cjn.0000000707

BibTeX
@article{Glenn2025,
  author = {Glenn, Dorey A and Carver, Ashley W and Helmuth, Margaret E and Smith, Abigail R and Lafayette, Richard A and Ravipati, Prasanth and Oliverio, Andrea L and Rizk, Dana V and Novak, Jan and Lugani, Francesca and Bartosh, Sharon M and Mucha, Krzysztof and Kiryluk, Krzysztof and Saha, Manish K and Nast, Cynthia C and Hou, Jean and Biederman, Laura E and Messias, Nidia and Rosenberg, Avi Z and Reich, Heather N and Canetta, Pietro A and Nachman, Patrick H and Nester, Carla and Bou-Matar, Raed and Wadhwani, Shikha and Mariani, Laura H and Khalid, Myda and CureGN IgA Working Group, CureGN IgA Working Group},
  title = {Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/Vasculitis},
  journal = {Clinical Journal of the American Society of Nephrology},
  year = {2025},
  volume = {20},
  number = {7},
  pages = {978--992},
  doi = {10.2215/cjn.0000000707}
}
Kostenlos starten →